DeepSeek: The “Watson” to Doctors – from Assistance to Collaboration

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture of Experts (MoE) architecture, multimodal data fusion capabilities, and significantly reduced training costs (over 90% lower than comparable models), DeepSeek achieves performance on par with […]

Continue Reading

Research Shows AI Technology Improves Parkinson’s Diagnoses

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement disorders share similarities, sometimes making a definitive diagnosis initially difficult. Although Parkinson’s disease is a well-recognized illness, the term can refer to a variety of conditions, […]

Continue Reading

New AI Tool Accelerates Disease Treatments

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by identifying not just which patient populations may benefit but also how the drugs work inside cells. The researchers have demonstrated the tool’s potential by identifying […]

Continue Reading

Customized Smartphone App Shows Promise in Preventing Further Cognitive Decline

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet, solving puzzles and increasing social interactions. Multidomain interventions, including games and exercises delivered through smartphone-based apps, have also proven effective in slowing cognitive decline in […]

Continue Reading

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer’s disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing MCI can be a long and difficult process, especially in rural areas where access to licensed neuropsychologists is limited. To increase accessibility to cognitive assessments, […]

Continue Reading